Search

A consortium of government, industry, and nonprofit partners will fund gene therapy clinical trials for three different rare diseases at UT Southwestern Medical Center and Children’s Health, where scientists are working on gene therapies to treat neurodevelopmental disorders in children.

Pregnant individuals should be careful regarding energy drinks and their overall intake of caffeine, according to an expert at UT Southwestern Medical Center.

The UT Southwestern medical student met with patients as part of the Hospital Elder Life Program (HELP), a joint effort between UTSW and the Hobson Wildenthal Honors College at the University of Texas at Dallas that sends student volunteers to help geriatric patients retain their cognitive skills

UT Southwestern Medical Center and its William P. Clements Jr. University Hospital have been named an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America (IDSA), recognizing a commitment to reducing infections caused by antimicrobial resistance.

Research led by UT Southwestern scientists suggests that an investigational drug could restore the ability of some non-small cell lung cancers (NSCLCs) to respond to an immune checkpoint blockade (ICB), a therapy that harnesses the immune system to fight malignant tumors.

UT Southwestern scientists have adapted a classic research technique called forward genetics to identify new genes involved in autism spectrum disorder (ASD).

UT Southwestern researchers have identified the structure of a key member of a family of proteins called nicotinic acetylcholine receptors in three different shapes.

New findings by UT Southwestern researchers help better understand the how one of the most commonly mutated genetic drivers of cancer passes signals that cause the disease.

A relative decline in wealth during midlife increases the likelihood of a cardiac event or heart disease after age 65 while an increase in wealth between ages 50 and 64 is associated with lower cardiovascular risk, according to a new study in JAMA Cardiology.

Cancer cells avoid an immune system attack after radiation by commandeering a cell signaling pathway that helps dying cells avoid triggering an immune response